Drug makers locked in bitter battles over medicine
NPPA’s latest list on defaulters show that total amount outstanding from the industry has snowballed to more than Rs 4,500 crore, ET has found.
Over the last two decades, drug makers have been locked in battles with India’s pricing watchdog, National Pharmaceutical Pricing Authority (NPPA), over claims that they have charged higher prices for several medicines than the government’s ceiling.
NPPA’s latest list on defaulters show that total amount outstanding from the industry has snowballed to more than Rs 4,500 crore, Prabha Raghavan finds.
COMMENTS
All Comments
By commenting, you agree to the Prohibited Content Policy
PostBy commenting, you agree to the Prohibited Content Policy
PostFind this Comment Offensive?
Choose your reason below and click on the submit button. This will alert our moderators to take actions